These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18756361)

  • 1. (18)F-FDG accumulation in the oral cavity is associated with periodontal disease and apical periodontitis: an initial demonstration on PET/CT.
    Shimamoto H; Tatsumi M; Kakimoto N; Hamada S; Shimosegawa E; Murakami S; Furukawa S; Hatazawa J
    Ann Nucl Med; 2008 Aug; 22(7):587-93. PubMed ID: 18756361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflection of ¹⁸F-FDG accumulation in the evaluation of the extent of periapical or periodontal inflammation.
    Kito S; Koga H; Kodama M; Yamamoto N; Kokuryo S; Habu M; Matsuo K; Nishino T; Kubota K; Muraoka K; Oda M; Wakasugi-Sato N; Matsumoto-Takeda S; Seta Y; Tanaka T; Miyamoto I; Yamashita Y; Kitamura C; Nakashima K; Takahashi T; Tominaga K; Morimoto Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Dec; 114(6):e62-9. PubMed ID: 23021921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
    Rosen RS; Fayad L; Wahl RL
    J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a new 18F-FDG PET/CT protocol in the staging of oral cavity carcinomas.
    Cistaro A; Palandri S; Balsamo V; Migliaretti G; Pentenero M; Testa C; Cusmà S; Ceraudo F; Gandolfo S; Ficola U
    J Nucl Med Technol; 2011 Mar; 39(1):7-13. PubMed ID: 21321252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
    Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
    J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.
    Tatsumi M; Cohade C; Nakamoto Y; Wahl RL
    Radiology; 2003 Dec; 229(3):831-7. PubMed ID: 14593193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
    Ben-Haim S; Kupzov E; Tamir A; Israel O
    J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
    Meerwein CM; Queiroz M; Kollias S; Hüllner M; Veit-Haibach P; Huber GF
    Swiss Med Wkly; 2015; 145():w14116. PubMed ID: 25701645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variety and complexity of fluorine-18-labelled fluoro-2-deoxy-D-glucose accumulations in the oral cavity of patients with oral cancers.
    Kito S; Koga H; Kodama M; Habu M; Kokuryo S; Yamamoto N; Oda M; Nishino T; Zhang M; Matsuo K; Wakasugi-Sato N; Matsumoto-Takeda S; Seta Y; Yoshiga D; Kaneuji T; Nogami S; Yoshioka I; Yamashita Y; Tanaka T; Miyamoto I; Kitamura C; Tominaga K; Morimoto Y
    Dentomaxillofac Radiol; 2013; 42(7):20130014. PubMed ID: 23610089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
    Sun XG; Huang G; Liu JJ; Wan LR
    Hell J Nucl Med; 2009; 12(2):115-8. PubMed ID: 19675862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.